Upgrade to SI Premium - Free Trial

Lilly (LLY) Announces FDA Has Approved CYRAMZA in Patients with HCC

May 13, 2019 6:46 AM
Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA® (ramucirumab ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles